251 related articles for article (PubMed ID: 15123119)
1. [Epidemiology of HPV infection].
Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
[TBL] [Abstract][Full Text] [Related]
2. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.
de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H;
Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes.
Beerens E; Van Renterghem L; Praet M; Sturtewagen Y; Weyers S; Temmerman M; Depypere H; Claeys P; Cuvelier CA
Cytopathology; 2005 Aug; 16(4):199-205. PubMed ID: 16048506
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay].
Oztürk S; Kaleli I; Kaleli B; Bir F
Mikrobiyol Bul; 2004 Jul; 38(3):223-32. PubMed ID: 15490841
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
10. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
11. HPV detection in cervical cancer patients in northern Poland.
Dybikowska A; Licznerski P; Podhajska A
Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
[TBL] [Abstract][Full Text] [Related]
12. [Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi Province, China].
Shen YH; Chen F; Huang MN; Liu B; Wang XX; Zhao FH; Li SM; Li N; Wu LY; Rong SD; Zhang WH; Ren SD; Huang RD; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):381-5. PubMed ID: 12974078
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
14. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting.
Carozzi FM; Del Mistro A; Confortini M; Sani C; Puliti D; Trevisan R; De Marco L; Tos AG; Girlando S; Palma PD; Pellegrini A; Schiboni ML; Crucitti P; Pierotti P; Vignato A; Ronco G
Am J Clin Pathol; 2005 Nov; 124(5):716-21. PubMed ID: 16203283
[TBL] [Abstract][Full Text] [Related]
16. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
17. A population-based study of vaginal human papillomavirus infection in hysterectomized women.
Castle PE; Schiffman M; Bratti MC; Hildesheim A; Herrero R; Hutchinson ML; Rodriguez AC; Wacholder S; Sherman ME; Kendall H; Viscidi RP; Jeronimo J; Schussler JE; Burk RD
J Infect Dis; 2004 Aug; 190(3):458-67. PubMed ID: 15243917
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
20. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
